381 related articles for article (PubMed ID: 33886098)
1. Riboflavin in Neurological Diseases: A Narrative Review.
Plantone D; Pardini M; Rinaldi G
Clin Drug Investig; 2021 Jun; 41(6):513-527. PubMed ID: 33886098
[TBL] [Abstract][Full Text] [Related]
2. Flavin adenine dinucleotide synthase deficiency due to FLAD1 mutation presenting as multiple acyl-CoA dehydrogenation deficiency-like disease: A case report.
Yamada K; Ito M; Kobayashi H; Hasegawa Y; Fukuda S; Yamaguchi S; Taketani T
Brain Dev; 2019 Aug; 41(7):638-642. PubMed ID: 30982706
[TBL] [Abstract][Full Text] [Related]
3. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
Bosch AM; Abeling NG; Ijlst L; Knoester H; van der Pol WL; Stroomer AE; Wanders RJ; Visser G; Wijburg FA; Duran M; Waterham HR
J Inherit Metab Dis; 2011 Feb; 34(1):159-64. PubMed ID: 21110228
[TBL] [Abstract][Full Text] [Related]
4. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.
Bosch AM; Stroek K; Abeling NG; Waterham HR; Ijlst L; Wanders RJ
Orphanet J Rare Dis; 2012 Oct; 7():83. PubMed ID: 23107375
[TBL] [Abstract][Full Text] [Related]
5. Brown-Vialetto-Van Laere syndrome: a riboflavin-unresponsive patient with a novel mutation in the C20orf54 gene.
Koy A; Pillekamp F; Hoehn T; Waterham H; Klee D; Mayatepek E; Assmann B
Pediatr Neurol; 2012 Jun; 46(6):407-9. PubMed ID: 22633641
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in riboflavin transporter RFVT and its genetic disease.
Jin C; Yonezawa A
Pharmacol Ther; 2022 May; 233():108023. PubMed ID: 34662687
[TBL] [Abstract][Full Text] [Related]
8. Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).
Horvath R
J Inherit Metab Dis; 2012 Jul; 35(4):679-87. PubMed ID: 22231380
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Missaglia S; Tavian D; Moro L; Angelini C
Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.
Manole A; Jaunmuktane Z; Hargreaves I; Ludtmann MHR; Salpietro V; Bello OD; Pope S; Pandraud A; Horga A; Scalco RS; Li A; Ashokkumar B; Lourenço CM; Heales S; Horvath R; Chinnery PF; Toro C; Singleton AB; Jacques TS; Abramov AY; Muntoni F; Hanna MG; Reilly MM; Revesz T; Kullmann DM; Jepson JEC; Houlden H
Brain; 2017 Nov; 140(11):2820-2837. PubMed ID: 29053833
[TBL] [Abstract][Full Text] [Related]
11. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.
Foley AR; Menezes MP; Pandraud A; Gonzalez MA; Al-Odaib A; Abrams AJ; Sugano K; Yonezawa A; Manzur AY; Burns J; Hughes I; McCullagh BG; Jungbluth H; Lim MJ; Lin JP; Megarbane A; Urtizberea JA; Shah AH; Antony J; Webster R; Broomfield A; Ng J; Mathew AA; O'Byrne JJ; Forman E; Scoto M; Prasad M; O'Brien K; Olpin S; Oppenheim M; Hargreaves I; Land JM; Wang MX; Carpenter K; Horvath R; Straub V; Lek M; Gold W; Farrell MO; Brandner S; Phadke R; Matsubara K; McGarvey ML; Scherer SS; Baxter PS; King MD; Clayton P; Rahman S; Reilly MM; Ouvrier RA; Christodoulou J; Züchner S; Muntoni F; Houlden H
Brain; 2014 Jan; 137(Pt 1):44-56. PubMed ID: 24253200
[TBL] [Abstract][Full Text] [Related]
12. Brown-Vialetto-Van Laere and Fazio-Londe syndromes: SLC52A3 mutations with puzzling phenotypes and inheritance.
Gayathri S; Gowda VK; Udhayabanu T; O'Callaghan B; Efthymiou S; Varalakshmi P; Benakappa N; Houlden H; Ashokkumar B
Eur J Neurol; 2021 Mar; 28(3):945-954. PubMed ID: 33325104
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
[TBL] [Abstract][Full Text] [Related]
14. An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency.
Mosegaard S; Bruun GH; Flyvbjerg KF; Bliksrud YT; Gregersen N; Dembic M; Annexstad E; Tangeraas T; Olsen RKJ; Andresen BS
Mol Genet Metab; 2017 Dec; 122(4):182-188. PubMed ID: 29122468
[TBL] [Abstract][Full Text] [Related]
15. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency.
O'Callaghan B; Bosch AM; Houlden H
J Inherit Metab Dis; 2019 Jul; 42(4):598-607. PubMed ID: 30793323
[TBL] [Abstract][Full Text] [Related]
16. Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation.
Abbas Q; Jafri SK; Ishaque S; Rahman AJ
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29950502
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience.
Jaeger B; Bosch AM
J Inherit Metab Dis; 2016 Jul; 39(4):559-64. PubMed ID: 26973221
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.
Henriques BJ; Lucas TG; Martins E; Gaspar A; Bandeira A; Nogueira C; Brandão O; Rocha H; Vilarinho L; Gomes CM
Curr Mol Med; 2019; 19(7):487-493. PubMed ID: 31418342
[TBL] [Abstract][Full Text] [Related]
19. Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect.
Cotelli MS; Vielmi V; Rimoldi M; Rizzetto M; Castellotti B; Bertasi V; Todeschini A; Gregorelli V; Baronchelli C; Gellera C; Padovani A; Filosto M
Neurol Sci; 2012 Dec; 33(6):1383-7. PubMed ID: 22190129
[TBL] [Abstract][Full Text] [Related]
20. SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.
Udhayabanu T; Subramanian VS; Teafatiller T; Gowda VK; Raghavan VS; Varalakshmi P; Said HM; Ashokkumar B
Clin Chim Acta; 2016 Nov; 462():210-214. PubMed ID: 27702554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
